Clinical Trial Update: CPI Combination Therapy for Autoimmune Encephalitis [NA]

View source ↗

Summary

The clinical trial evaluating a CPI combination therapy for autoimmune encephalitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• CPI Combination Therapy

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Autoimmune Encephalitis | NA | Status: COMPLETED